{
    "clinical_study": {
        "@rank": "121129", 
        "acronym": "ELECTRE2", 
        "arm_group": {
            "arm_group_label": "Essential tremor", 
            "arm_group_type": "Experimental", 
            "description": "30 patients with essential tremor"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether transcranial cathodal direct current\n      stimulation (tDCS) delivered over the cerebellum can improve essential tremor."
        }, 
        "brief_title": "Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Essential Tremor", 
        "condition_browse": {
            "mesh_term": [
                "Tremor", 
                "Essential Tremor"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \u2265 18 years and \u2264 65 years\n\n          -  Important essential tremor (bilateral postural and/or action tremor since more than\n             one year)\n\n          -  Normal physical and neurological examination, except for essential tremor\n\n          -  Insufficient efficiency of usual essential tremor's treatment\n\n          -  No treatment altering the cortical excitability\n\n          -  Agreement to use a medically acceptable method of contraception throughout the study\n             for female of childbearing potential\n\n          -  mini-mental status score >24\n\n        Exclusion Criteria:\n\n          -  Age < 18 years and > 65 years\n\n          -  Current neurological or psychiatric illness other than essential tremor\n\n          -  Individual who is on medication which is known to lower seizure threshold\n\n          -  Previous history of seizure, loss of conciousness or current active epilepsy\n\n          -  Contraindication for MRI or TMS study\n\n          -  Intake of antiepileptic medications for essential tremor  (barbiturates, gabapentine,\n             topiramate, clonazepam), within the 7 days preceeding the first visit\n\n          -  alcohol intake within the 24 hours preceeding the first visit\n\n          -  Pregnancy, breast feeding women and women who are of childbearing age and not\n             practicing adequate birth control\n\n          -  Individual who have MMS \u2264 24/30 or patients legally protected or inability to provide\n             an informed consent\n\n          -  Simultaneous participation in another clinical trial\n\n          -  Patients who are not enrolled at social security"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02052271", 
            "org_study_id": "C13-24", 
            "secondary_id": "2013-A01404-41"
        }, 
        "intervention": {
            "arm_group_label": "Essential tremor", 
            "description": "Active stimulation: duration: 20 mn, intensity: 2 mA; localisation : cerebellum; Placebo stimulation: duration: 9 seconds, intensity: 2 mA; localisation cerebellum;", 
            "intervention_name": "Cathodal cerebellar transcranial direct current stimulation", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "essential tremor", 
            "cerebellum", 
            "transcranial direct current stimulation", 
            "electrophysiology"
        ], 
        "lastchanged_date": "January 30, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75651"
                }, 
                "name": "Institut du Cerveau et de la Moelle, H\u00f4pital Piti\u00e9-Salp\u00e9tri\u00e8re"
            }, 
            "investigator": {
                "last_name": "Emmanuel FLAMAND-ROZE", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Th\u00e9rapeutique exp\u00e9rimentale du Tremblement Essentiel Par la Stimulation Transcranienne Par Courant Direct (tDCS) du Cortex Cerebelleux", 
        "overall_contact": {
            "email": "emmanuelle.apartis@sat.aphp.fr", 
            "last_name": "Emmanuelle Apartis, MD, PhD", 
            "phone": "+33(0)1 49 28 23 07"
        }, 
        "overall_official": {
            "affiliation": "Institut du Cerveau et de la Moelle et F\u00e9d\u00e9ration de Neurologie de l'H\u00f4pital Piti\u00e9-Salp\u00e9tri\u00e8re, Paris", 
            "last_name": "Emmanuel Flamand-Roze, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in tremor amplitude on clinical rating scale", 
            "safety_issue": "No", 
            "time_frame": "10 minutes after the end of tDCS"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02052271"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in tremor amplitude on accelerometric recording", 
                "safety_issue": "No", 
                "time_frame": "During tDCS, 10 mn, 60 mn and 90 mn after the end of tDCS"
            }, 
            {
                "measure": "Change from baseline in tremor amplitude on electromyographic recordings", 
                "safety_issue": "No", 
                "time_frame": "During tDCS, 10 mn, 60 mn and 90 mn after the end of tDCS"
            }, 
            {
                "measure": "Change from baseline in tremor amplitude on digitized tablet", 
                "safety_issue": "No", 
                "time_frame": "During tDCS, 10 mn, 60 mn and 90 mn after the end of tDCS"
            }, 
            {
                "measure": "Change from baseline in tremor amplitude on clinical rating scale", 
                "safety_issue": "No", 
                "time_frame": "During tDCS, 60 mn and 90 mn after the end of tDCS"
            }, 
            {
                "measure": "Change from baseline of amplitude of motor evoked potentials elicited by TMS", 
                "safety_issue": "No", 
                "time_frame": "10 mn, 60 mn and 90 mn after tDCS"
            }
        ], 
        "source": "Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale, France", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale, France", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}